Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
RESEARCH TOOLSreports
Holding MDGL?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 22, 2024 | xxxxxxxxxxxxx | $218041 | |
| Sep 11, 2024 | William John Sibold President & Ceo,director | xxxxxxxxxxxxx | $1551490 |
| Jun 18, 2024 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $532000 |
| Jun 14, 2024 | Robert E. Waltermire Svp, Chief Pharma Dev | xxxxxxxxxxxxx | $570000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $8092585 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $31215439 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $433353240 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,159,230 | Insider | 9.90% | 710,904,885 | |
| 2,042,000 | Institution | 9.36% | 672,308,080 | |
| 1,974,590 | Institution | 9.05% | 650,114,012 | |
| 1,794,831 | Insider | 8.23% | 590,930,158 | |
| 1,748,975 | Institution | 8.02% | 575,832,529 | |
| 1,713,438 | Institution | 7.86% | 564,132,327 | |
| 1,596,833 | Institution | 7.32% | 525,741,297 | |
| 1,114,539 | Insider | 5.11% | 366,950,820 | |
| 841,989 | Insider | 3.86% | 277,216,458 | |
| 832,508 | Institution | 3.82% | 274,094,934 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,713,438 | Institution | 7.86% | 564,132,327 | |
| 1,596,833 | Institution | 7.32% | 525,741,297 | |
| 329,178 | Institution | 1.51% | 108,378,565 | |
| 293,510 | Institution | 1.35% | 96,635,232 | |
| 282,106 | Institution | 1.29% | 92,880,579 | |
| 214,256 | Institution | 0.98% | 70,541,645 | |
| 195,668 | Institution | 0.90% | 64,421,732 | |
| 194,448 | Institution | 0.89% | 64,020,060 | |
| 111,424 | Institution | 0.51% | 36,685,238 | |
| 97,158 | Institution | 0.45% | 31,988,300 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 476,464 | Institution | 2.18% | 156,871,007 | |
| 474,130 | Institution | 2.17% | 150,341,882 | |
| 575,442 | Institution | 2.64% | 149,235,128 | |
| 462,839 | Institution | 2.12% | 120,032,666 | |
| 312,721 | Institution | 1.43% | 81,101,064 | |
| 253,791 | Institution | 1.16% | 65,818,158 | |
| 158,138 | Institution | 0.73% | 52,065,355 | |
| 125,914 | Institution | 0.58% | 41,455,925 | |
| 82,090 | Institution | 0.38% | 26,029,918 | |
| 80,045 | Institution | 0.37% | 20,758,870 |
FAQ
Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
Currently, no data Available
What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
Currently, no data Available
What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
Behzad Aghazadeh owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.